The world is rapidly aging. According to the World Health Organization, 12% of the world population was aged 60 and above in 2015 and by 2050, that number will rise to 22%. Along with this demographic shift, there is an increase in the prevalence of age-related chronic diseases including cancer, liver fibrosis, and Alzheimer’s disease in which senescent cells have been implicated.
About The Author
Related Posts
Senolytics in the News
- Fighting ageing with immune checkpoint blockade
- Despite Their Scary Name, Some ‘Zombie’ Cells May Not Be All Bad
- Focus on frailty: New senolytic holds potential for sarcopenia treatment
- Progress in Emerging Alzheimer’s Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer’s Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer’s Disease Conference
- Senolytic treatment shows promise in DME, wet AMD